William Blair assumed coverage on shares of Phreesia (NYSE:PHR) in a report issued on Monday morning, Briefing.com Automated Import reports. The firm issued an outperform rating on the stock.
Separately, Chardan Capital assumed coverage on Phreesia in a research note on Tuesday, July 23rd. They issued a buy rating and a $33.00 price target on the stock. Five equities research analysts have rated the stock with a buy rating, The stock currently has a consensus rating of Buy and an average price target of $30.50.
PHR stock opened at $25.25 on Monday. Phreesia has a 1 year low of $23.00 and a 1 year high of $29.38.
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.
Recommended Story: Bollinger Bands
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.